News

Archive

August 2, 2019

Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2019 Financial Results

Archive

July 8, 2019

Deciphera Pharmaceuticals, Inc. Announces Appointment of Susan L. Kelley, M.D., to its Board of Directors

Archive

June 11, 2019

Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China

Archive

June 10, 2019

Deciphera Pharmaceuticals, Inc. Expands Pipeline with Potential First-in-Class Autophagy Inhibitor to Treat Mutant RAS Cancers

Archive

May 30, 2019

Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Global Healthcare Conference

Archive

May 14, 2019

Deciphera Pharmaceuticals, Inc. to Present at the UBS Global Healthcare Conference

Archive

May 9, 2019

Deciphera Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results

Archive

March 14, 2019

Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Year-end 2018 Financial Results

Archive

March 4, 2019

Deciphera Pharmaceuticals, Inc. Announces Retirement of Michael D. Taylor, Ph.D.

Archive

February 7, 2019

Deciphera Pharmaceuticals, Inc. to Present at the 1st Annual Guggenheim Healthcare Talks Idea Forum Oncology Day

Back to top